Celltrion’s COVID-19 treatment shows promise against South African variant
April 30, 2021Medical Communications COVID-19, celltrion, covid 19 news, covid-19 news, covid-19 treatment, pharma, pharma news
Celltrion’s regdanvimab treatment for COVID-19 has shown itself to be effective against the South African variant of the virus, according …
Melanoma market to reach $7.4bn by 2029
April 30, 2021Medical Communications melanoma
A report from GlobalData, Melanoma – Global Drug Forecast and Market Analysis to 2029, has predicted the melanoma industry will …
Scipher Medicine to expand into autoimmune disease therapeutics
April 30, 2021Medical Communications AI, autoimmune diseases
Scipher Medicine, a precision immunology company, announced the launch on Scipher Therapeutics on Thursday, marking the company’s shift towards the …
Positive phase III results achieved for dialysis drug in China
April 30, 2021Medical Communications China, Kideny disease
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced positive results from a phase-III study in China (PA-CL-CHINA-01), evaluating the …
Takeda’s lung cancer drug granted FDA priority review
April 29, 2021FDA, Takeda, lung cancer treatment, pharma, pharma news
The FDA has granted priority review for Takeda’s New Drug Application (NDA) for its mobocertinib drug for the treatment of …
Pharnext CMT drug shows positive Phase III results
April 29, 2021CMT, Charcot-Marie-Tooth Disease, Phase III trial, pharma, pharma news, pharnext
Pharnext SA’s PXT3003 treatment for patients with Charcot-Marie-Tooth Disease (CMT) has shown positive interim results in its ongoing Phase III …
EC approves Kaftrio as combination treatment for cystic fibrosis
April 29, 2021EU, European Commission, cystic fibrosis
Vertex Pharmaceuticals has been granted European Commission approval for the label extension of Kaftrio (ivacaftor/tezacaftor/elexacaftor) in a combination regimen with …
Bristol Myers Squibb psoriasis drug shows positive Phase III results
April 29, 2021Bristol-Myers Squibb, bristol myers squibb, pharma, pharma news, psoriasis, psoriasis treatment
Bristol Myers Squibb’s investigational deucravacitinib drug, for the treatment of moderate-to-severe plaque psoriasis, has shown positive results in two Phase …
Moderna up investments to produce 3 billion COVID vaccine doses in 2022
April 29, 2021COVID-19, Moderna, Vaccine, investment
Moderna have announced it is making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which …
Pharmafile.com’s weekly COVID-19 news round-up
April 28, 2021Research and Development COVID-19, covid 19 news, covid-19 news, news roundup, pharma, pharma news
The past week has seen plenty of COVID-19 news continue to roll in: The European Commission has sued AstraZeneca over …
COVID Symptom Study app reveals most common vaccine side effects
April 28, 2021Research and Development COVID-19, Vaccine, data
An analysis of over 600,000 people’s vaccine reports has been published in The Lancet Infectious Diseases journal, in the largest …
Calliditas’ kidney disease drug granted priority review by FDA
April 28, 2021Research and Development Calliditas, FDA, nephropathy, pharma, pharma news
The FDA has granted priority review for the New Drug Applicaton (NDA) for Calliditas Therapeutics’ Nefecon, for the treatment of …
NICE to join GetReal Institute alongside nine key healthcare players
April 28, 2021Research and Development EU, NICE, rwe
NICE has announced it will join with nine other organisations to form the GetReal Institute, a not-for-profit multi-stakeholder enterprise, as …
Single dose of COVID vaccine can cut transmissions in half
April 28, 2021Research and Development COVID-19, Public Health England, Vaccine
A Public Health England (PHE) study into the Pfizer-BioNTech and Oxford-AstraZeneca vaccines has found that a single dose of either …
Sheila Frame new President for the Americas at Amryt
April 27, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Biopharmaceutical company Amryt have appointed Sheila Frame as President for the Americas.
Francesco Maria Lavino appointed CEO of F2G Ltd
April 27, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
F2G Limited has announced that Francesco Maria Lavino has been appointed Chief Executive Officer and member of the Board of …
Macrogen Europe appoints Dr Bongcho Kim as new CEO
April 27, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Macrogen Europe have announced the appointment of a new CEO, Dr Bongcho Kim, who joins the company after a successful …
King & Spalding announce appointment of former FDA official
April 27, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Eva Temkin, a former senior FDA official for therapeutic biologics and biosimilars, has joined King & Spalding in Washington, US, …
Are we on the cusp of an AI revolution?
April 27, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The pharmaceutical industry has historically been slow to adapt to change, with high regulatory hurdles and widespread scepticism facing new …
Navigating through the post-COVID-19 R&D bottleneck
April 27, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Jack Goddard inve
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
